Peter Greenleaf Insider Trading $BDSI BIODELIVERY SCIENCES INTERNATIONAL INC
Get free email notifications about insider trading for Peter Greenleaf.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Greenleaf. Peter Greenleaf is Senior VP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and SVP, Sales & Marketing in MEDIMMUNE INC /DE ($MEDI) and SVP, Sales and Marketing in MEDIMMUNE INC /DE ($MEDI) and Director in ANTARES PHARMA, INC. ($ATRS) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and Director in Mast Therapeutics, Inc. ($MSTX) and CEO in Sucampo Pharmaceuticals, Inc. ($SCMP) and Chief Executive Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in EYEGATE PHARMACEUTICALS INC ($EYEG) and Director in Mirna Therapeutics, Inc. ($MIRN) and in Cerecor Inc. ($CERC) and Chief Executive Officer in Cerecor Inc. ($CERC) and Director in Cerecor Inc. ($CERC) and Chief Executive Officer in Aurinia Pharmaceuticals Inc. ($AUPH).
Peter Greenleaf in BIODELIVERY SCIENCES INTERNATIONAL INC
Trading Symbol: BDSIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter Greenleaf: Director
Holdings: 59,788 shares
Current Value: $116,587
Latest Transaction: Aug 11 2020
$BDSI Market Capitalization: $106.88M
$BDSI Previous Close: $1.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Greenleaf in BIODELIVERY SCIENCES INTERNATIONAL INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRS, AUPH, BDSI, CERC, EYEG, MEDI, SVRA, SCMP, SYBX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 11 2020 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Option Exercise | M | 0.00 | 35,000 | 0 | 52,500 | |
Aug 11 2020 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Buy | M | 0.00 | 35,000 | 0 | 59,788 | 24.8 K to 59.8 K (+141.20 %) |
Aug 15 2019 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Option Exercise | M | 0.00 | 21,144 | 0 | 87,500 | |
Aug 15 2019 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Buy | M | 0.00 | 21,144 | 0 | 24,788 | 3.6 K to 24.8 K (+580.24 %) |
Aug 16 2018 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Option Exercise | M | 0.00 | 3,644 | 0 | 108,644 | |
Aug 16 2018 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Buy | M | 0.00 | 3,644 | 0 | 3,644 | 0 to 3.6 K |
Aug 03 2018 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Option Exercise | A | 2.93 | 64,164 | 188,001 | 64,164 | |
Aug 03 2018 | BDSI | BIODELIVERY SCIENC ... | Greenleaf Peter | Director | Option Exercise | A | 0.00 | 112,288 | 0 | 112,288 |
Page: 1